JP2023507622A5 - - Google Patents

Info

Publication number
JP2023507622A5
JP2023507622A5 JP2022537719A JP2022537719A JP2023507622A5 JP 2023507622 A5 JP2023507622 A5 JP 2023507622A5 JP 2022537719 A JP2022537719 A JP 2022537719A JP 2022537719 A JP2022537719 A JP 2022537719A JP 2023507622 A5 JP2023507622 A5 JP 2023507622A5
Authority
JP
Japan
Prior art keywords
candidate
therapy
changes
insulin
improvement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022537719A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507622A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065321 external-priority patent/WO2021126985A1/en
Publication of JP2023507622A publication Critical patent/JP2023507622A/ja
Publication of JP2023507622A5 publication Critical patent/JP2023507622A5/ja
Pending legal-status Critical Current

Links

JP2022537719A 2019-12-18 2020-12-16 治療ゾーン鑑定器 Pending JP2023507622A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962950029P 2019-12-18 2019-12-18
US62/950,029 2019-12-18
PCT/US2020/065321 WO2021126985A1 (en) 2019-12-18 2020-12-16 Therapeutic zone assessor

Publications (2)

Publication Number Publication Date
JP2023507622A JP2023507622A (ja) 2023-02-24
JP2023507622A5 true JP2023507622A5 (https=) 2023-12-27

Family

ID=76438708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022537719A Pending JP2023507622A (ja) 2019-12-18 2020-12-16 治療ゾーン鑑定器

Country Status (7)

Country Link
US (2) US20210193279A1 (https=)
EP (1) EP4076156A4 (https=)
JP (1) JP2023507622A (https=)
CN (1) CN114901127B (https=)
AU (1) AU2020407059A1 (https=)
CA (1) CA3162916A1 (https=)
WO (1) WO2021126985A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4076156A4 (en) 2019-12-18 2024-01-10 Dexcom, Inc. THERAPY ZONE EVALUator
WO2024010827A1 (en) 2022-07-05 2024-01-11 Biolinq Incorporated Sensor assembly of a microneedle array-based continuous analyte monitoring device
WO2026073051A1 (en) * 2024-09-30 2026-04-02 Dexcom, Inc. Optimizing event identification by performing patient-specific analyte data transforms

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2404262C (en) * 2000-03-29 2009-03-24 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US20080154513A1 (en) * 2006-12-21 2008-06-26 University Of Virginia Patent Foundation Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
KR101183854B1 (ko) 2007-06-27 2012-09-20 에프. 호프만-라 로슈 아게 테라피 시스템용 환자 정보 입력 인터페이스
US9220456B2 (en) * 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
DK3173014T4 (da) * 2009-07-23 2026-03-30 Abbott Diabetes Care Inc Realtidsstyring af data vedrørende fysiologisk kontrol af glucoseniveauer
WO2011050337A1 (en) * 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
EP2748747B1 (en) * 2011-08-26 2020-08-26 University Of Virginia Patent Foundation Method, system and computer readable medium for adaptive advisory control of diabetes
EP2798546B1 (en) * 2011-09-13 2020-12-23 Novo Nordisk A/S Adaptive system for optimizing a drug dosage regimen over time
US10391242B2 (en) 2012-06-07 2019-08-27 Medtronic Minimed, Inc. Diabetes therapy management system for recommending bolus calculator adjustments
US10102344B2 (en) * 2013-03-14 2018-10-16 Roche Diabetes Care, Inc. System and methods for analyzing blood glucose data and quantifying the success or failure of insulin therapy
US20160082187A1 (en) * 2014-09-23 2016-03-24 Animas Corporation Decisions support for patients with diabetes
US10638981B2 (en) 2015-02-16 2020-05-05 University Of Virginia Patent Foundation Method, system and computer readable medium for assessing actionable glycemic risk
US20160328990A1 (en) * 2015-05-07 2016-11-10 Dexcom, Inc. System and method for educating users, including responding to patterns
US10806859B2 (en) * 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US20170235909A1 (en) * 2016-02-11 2017-08-17 Esvyda!, Inc. Telemonitoring system !
EP4685812A3 (en) 2018-02-09 2026-04-22 DexCom, Inc. System for decision support
EP4076156A4 (en) 2019-12-18 2024-01-10 Dexcom, Inc. THERAPY ZONE EVALUator

Similar Documents

Publication Publication Date Title
US11679201B2 (en) Blood glucose control system with carbohydrate therapy indication
Feig et al. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial
JP2023507622A5 (https=)
Renard et al. Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home
Evans et al. Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control
Messori et al. Individually adaptive artificial pancreas in subjects with type 1 diabetes: a one-month proof-of-concept trial in free-living conditions
EP3785276A1 (en) Personalized closed loop medication delivery system that utilizes a digital twin of the patient
JP2022551265A (ja) 血中グルコース制御システム
JP2018502341A5 (https=)
Spaic et al. Predictive hyperglycemia and hypoglycemia minimization: in-home evaluation of safety, feasibility, and efficacy in overnight glucose control in type 1 diabetes
Lee et al. Continuous glucose monitoring for the internist
Corren et al. How important is adherence to inhaled medications before starting a biologic therapy for asthma?
Sekizuka et al. Effect of oral appliance therapy on blood pressure in Japanese patients with obstructive sleep apnea
Karol et al. A novel algorithm for the management of inpatient COVID-19 glucocorticoid-induced hyperglycemia
Swaminathan Predicting basal insulin rates on insulin pumps in Indian patients with type 1 diabetes: The rule of 5
Fellers Modification of a Screening Protocol to Evaluate Obstructive Sleep Apnea in a Pulmonary Clinic Setting
Ameck Using Smartphone Technology to Enhance Self-Management Support in Adults with Type 2 Diabetes in Primary Care
de Pouvourville et al. Economic analyses of freestyle libre systems for people living with diabetes: a systematic literature review
Shah et al. Effects of Home Blood Sugar Monitoring on HbA1c Among Diabetes Mellitus Patients Attending a Tertiary Care Hospital in Peshawar: Effects of Home Blood Sugar Monitoring on HbA1c Levels
Li et al. Initiation of Hybrid Closed‐Loop Artificial Pancreas System Improves Glycemic Control in a Hospitalized Type 1 Diabetes: A Case Report and Review
Nishat et al. Outcomes in Type II Diabetes Patients through the Covid 19 Pandemic A Retrospective Chart Review
Connery et al. Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
MacEwan et al. Economic impact of disease progression in Medicare patients with relapsed multiple myeloma
Hnoosh et al. Direct Costs of Type 2 Diabetes from the Brazilian Public Health Care Sector Perspective
Petrovski et al. Interpreting Sensor Augmented Pump in Type 1 Diabetes: A 5-Step Approach Protocol Using Carelink Therapy Software